pharma news today obesity drugs glp-1 🧬 Could this be the future of treatment? Scientists in Germany have developed an experimental “Trojan Horse” weight-loss drug designed to outperform existing therapies like Ozempic and Wegovy. The next-generation treatment Could weight-loss drugs eat the

Table of Contents The Rise of GLP-1 Injection in India: Weight Loss, Reimagined Understanding the Disruption in the Fitness Industry But why all the buzz

Saxenda may not be safe for everyone

The reduction was primarily driven by a 39% decrease in non-fatal stroke (HR 0.61), with trends toward reduced MI (HR 0.74) and cardiovascular death (HR 0.98) [7]

An inverse correlation is observed between plasma PYY and BMD in populations with weight gain and obesity (decreased PYY and increased BMD) and in weight loss scenarios (increased PYY and decreased BMD), as observed in patients with anorexia and amenorrheic athletes [81]